Home › Funds › Defilade Capital Management, L.P. › ELAN
Defilade Capital Management, L.P. position in ELAN
ELANCO ANIMAL HEALTH INC · Health Care
Defilade Capital Management, L.P. reported holding 864,080 shares of ELAN (ELANCO ANIMAL HEALTH INC) in its Q2 2026 13F filing — a position valued at US$21.3M, representing 2.85% of its reported portfolio and ranking #15 among its reported holdings. Defilade Capital Management, L.P. has disclosed ELAN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Defilade Capital Management, L.P.'s ELAN position evolved
Defilade Capital Management, L.P. first disclosed a stake in ELAN in Q4 2025 at 401,283 shares (US$9.1M). The position peaked in Q1 2026 at 931,121 shares, worth US$22.3M. Across 3 filings, Defilade Capital Management, L.P. increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 864,080 shares valued at US$21.3M — a reduction of -67,041 shares quarter over quarter.. Notable position changes include a 132% increase in Q1 2026 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 401.28K | $9.08M | New |
| Q1 2026 | 931.12K | $22.28M | Add |
| Q2 2026 | 864.08K | $21.27M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELAN and 13F data
ELAN (ELANCO ANIMAL HEALTH INC) is a Health Care company. 42 other funds we track also report a position in ELAN — the largest reported positions include Dodge & Cox (US$1.66B), DODGE & COX (US$1.66B), PRIMECAP MANAGEMENT CO/CA/ (US$1.12B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELAN
- Dodge & Cox 67.40M sh · $1.66B · Q2 2026
- DODGE & COX 67.40M sh · $1.66B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 45.45M sh · $1.12B · Q2 2026
- T. Rowe Price Investment Management, Inc. 28.75M sh · $707.56M · Q2 2026
- Winslow Capital Management, LLC 13.51M sh · $332.51M · Q2 2026
- Black Creek Investment Management Inc. 13.05M sh · $321.07M · Q2 2026
- JUPITER ASSET MANAGEMENT LTD 4.22M sh · $103.84M · Q2 2026
- Artemis Investment Management LLP 4.61M sh · $103.26M · Q3 2026
- SHAPIRO CAPITAL MANAGEMENT LLC 2.65M sh · $65.25M · Q2 2026
More on Defilade Capital Management, L.P.
FAQ
How long has Defilade Capital Management, L.P. held ELAN?
Defilade Capital Management, L.P. has disclosed ELAN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Defilade Capital Management, L.P.'s current position in ELAN?
As of Q2 2026, Defilade Capital Management, L.P. holds 864.08K shares of ELAN (ELANCO ANIMAL HEALTH INC), valued at $21.27M, representing 2.85% of its reported portfolio and ranking #15.
Has Defilade Capital Management, L.P. been buying or selling ELAN?
In the latest 13F filing (Q2 2026), Defilade Capital Management, L.P. reduced its position in ELAN. The position peaked in Q1 2026 at 931.12K shares.
Which other funds hold ELAN?
Other major institutional holders of ELAN include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.